These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21908483)

  • 1. Statin therapy and multiple sclerosis disability in a population-based cohort.
    Paz Soldán MM; Pittock SJ; Weigand SD; Yawn BP; Rodriguez M
    Mult Scler; 2012 Mar; 18(3):358-63. PubMed ID: 21908483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin treatment in multiple sclerosis: a systematic review and meta-analysis.
    Pihl-Jensen G; Tsakiri A; Frederiksen JL
    CNS Drugs; 2015 Apr; 29(4):277-91. PubMed ID: 25795002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disability profile of MS did not change over 10 years in a population-based prevalence cohort.
    Pittock SJ; Mayr WT; McClelland RL; Jorgensen NW; Weigand SD; Noseworthy JH; Rodriguez M
    Neurology; 2004 Feb; 62(4):601-6. PubMed ID: 14981177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in MS-related disability in a population-based cohort: a 10-year follow-up study.
    Pittock SJ; Mayr WT; McClelland RL; Jorgensen NW; Weigand SD; Noseworthy JH; Weinshenker BG; Rodriguez M
    Neurology; 2004 Jan; 62(1):51-9. PubMed ID: 14718697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a.
    Rudick RA; Pace A; Rani MR; Hyde R; Panzara M; Appachi S; Shrock J; Maurer SL; Calabresi PA; Confavreux C; Galetta SL; Lublin FD; Radue EW; Ransohoff RM
    Neurology; 2009 Jun; 72(23):1989-93. PubMed ID: 19506220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis.
    Hirst C; Ingram G; Swingler R; Compston DA; Pickersgill T; Robertson NP
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1137-43. PubMed ID: 18303106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term improvement in outcome after intracerebral hemorrhage in patients treated with statins.
    Winkler J; Shoup JP; Czap A; Staff I; Fortunato G; McCullough LD; Sansing LH
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e541-5. PubMed ID: 23867041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment?
    Antonini-Canterin F; Popescu BA; Huang G; Korcova-Miertusova R; Rivaben D; Faggiano P; Pavan D; Piazza R; Bolis A; Ciavattone A; Ruggiero A; Nicolosi GL
    Ital Heart J; 2005 Feb; 6(2):119-24. PubMed ID: 15819504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota.
    Rodriguez M; Siva A; Ward J; Stolp-Smith K; O'Brien P; Kurland L
    Neurology; 1994 Jan; 44(1):28-33. PubMed ID: 8290086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
    JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study.
    Lin TK; Chou P; Lin CH; Hung YJ; Jong GP
    PLoS One; 2018; 13(5):e0196713. PubMed ID: 29723231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis.
    Antonini-Canterin F; Hîrşu M; Popescu BA; Leiballi E; Piazza R; Pavan D; Ginghină C; Nicolosi GL
    Am J Cardiol; 2008 Sep; 102(6):738-42. PubMed ID: 18773999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of statins in combination with interferon therapy in multiple sclerosis: a meta-analysis.
    Bhardwaj S; Coleman CI; Sobieraj DM
    Am J Health Syst Pharm; 2012 Sep; 69(17):1494-9. PubMed ID: 22899744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statins.
    Feng X; Han D; Kilaru BK; Franek BS; Niewold TB; Reder AT
    Arch Neurol; 2012 Oct; 69(10):1303-9. PubMed ID: 22801747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between statin use and open-angle glaucoma.
    Stein JD; Newman-Casey PA; Talwar N; Nan B; Richards JE; Musch DC
    Ophthalmology; 2012 Oct; 119(10):2074-81. PubMed ID: 22727176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care utilization in multiple sclerosis: a population-based study in Olmsted County, MN.
    Stolp-Smith KA; Atkinson EJ; Campion ME; O'Brien PC; Rodriguez M
    Neurology; 1998 Jun; 50(6):1594-600. PubMed ID: 9633699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of glatiramer acetate compared to other multiple sclerosis therapies.
    Izquierdo G; García-Agua Soler N; Rus M; García-Ruiz AJ
    Brain Behav; 2015 Jun; 5(6):e00337. PubMed ID: 26085963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.